Information sent to healthcare professionals in May 2010 about the safety of medicines

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

A list of letters sent to healthcare professionals in May 2010, to inform of new safety information and advice about medicines.

Date issued Product Safety information
27 May 2010 Perfalgan (intravenous paracetamol)PDF file (opens in new window) (87Kb) Risk of accidental overdose in infants and children.
24 May 2010 Keppra (levetiracetam)PDF file (opens in new window) (103Kb) Now approved for use as adjunctive therapy in children from one month of age.

Page last modified: 08 June 2010